We’re delighted to add a summary of a recent presentation titled: Clinical Update on the Management of Psoriasis and Psoriatic Arthritis: The Role of Bimekizumab.
Chaired by Associate Professor Stephen Shumack at the recent ACD meeting, the symposium featured speakers Dr Diana Rubel and Dr Andrew Lim who discussed the role of IL-17A and IL-17F in skin and joint symptoms in presentations on the current management of psoriasis and PsA.
Please login below to download this issue (PDF)